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Seizures are sudden abnormal electrical activity in the brain that lead to 
excitotoxic tissue damage, changes in mood and behavior, and even death. Vascular 
endothelial growth factor (VEGF) has been shown to protect against seizure and 
excitotoxic injury in rats. We have recently shown that neural stem and progenitor cells 
(NSPCs) produce a significant amount of the VEGF in the dentate gyrus (DG). In order 
to study the contribution of NSPC produced VEGF in modulating seizures and their 
sequelae, we used VEGFfl/flNestinCreERT2 mice in a kainic acid (KA) induced 
excitotoxicity model. Using VEGFfl/flNestinCreERT2 mice following tamoxifen (TAM) 
injection allows for the inducible knock down (KD) of VEGF in NSPCs. After either KA or 
vehicle treatment, mice were given hippocampus-dependent behavioral tests consisting 
of a novel arm test in a Y maze, an object location test (OLT), and an elevated plus 
maze (EPM). Analysis of the novel arm test and the OLT confirm that the KA treatment 
impaired memory. Surprisingly, NSPC-specific VEGF KD seems to result in decreased 
memory at baseline compared to control mice and may or may not be further impacted 
by excitotoxic injury. Analysis of the EPM suggests that VEGF KD and KA treatment 
had no effects on mice’s anxiety-like behavior. Elucidating the functional effects of 
NSPC-derived factors such as VEGF in the context of injury is a critical step to 
understanding how stem cells modulate brain function and will aid in the successful 
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 Epilepsy, a neurological disorder characterized by repetitive seizures, affects 
more than 50 million people worldwide1. Seizures are a sudden, uncontrolled electrical 
disturbance in the brain, and they can lead to excitotoxic brain injury which is a 
pathological process of neuron damage caused by overactivation of glutamate 
receptors2, 3. While there are numerous antiepileptic treatments currently used to treat 
patients suffering from recurrent seizures, these therapies often do not completely 
prevent seizures and also have significant adverse effects1. Thus, scientists have begun 
exploring NSPCs as a potential new therapeutic for excitotoxic brain injury.  
 NSPCs are consisted of neural stem cells (NSCs) and neural progenitor cells 
(NPCs). NSCs are the stem cells which are self-renewing and multipotent in the 
nervous system and can differentiate into neural sub-types such as neurons, astrocytes 
and oligodendrocytes3, 5. NPCs are the cells directly differentiated from NSCs and have 
limited number of dividing times and restricted capability to differentiate into neuronal 
and glial cell types6. Collectively, these NSPCs reside in two major neurogenic niches in 
the brain throughout the mammalian lifespan including the subventricular zone of the 
forebrain and the subgranular zone of the DG of the hippocampus7. Previous research 
shows that NSPCs located in the DG of the hippocampus can mediate memory and 
emotions through the production of new neurons in a process called neurogenesis8, 9. It 
has been shown that seizures can acutely stimulate NSPCs to increase production of 
new dentate granule cells which contribute to aberrant network reorganization in the 
hippocampus and subsequent cognitive impairments10, 11. By contrast, chronic seizures 
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could reduce the neurogenesis possibly due to the exhaustion of NSPC pool or 
alterations of neurogenic niche disrupting proper functions of NSPCs12, 13. 
 Incidentally, previous studies have shown that VEGF is upregulated after 
seizure-induced excitotoxic injury14, 15, 16. Interestingly, VEGF, the growth factor 
commonly associated with angiogenesis, has also been shown to protect against 
seizure and excitotoxic injury in rats17, 18. Most previous research assumes that 
neuroprotective VEGF in the brain comes from astrocytes19. Our lab has shown that 
NSPCs, in addition to their neurogenic functions, also produce a variety of growth 
factors and cytokines that are known to modulate inflammation20, 21. In particular, our lab 
has found that NSPCs produce almost one third of the VEGF in the relatively astrocyte-
sparse DG. To date, no research has studied the effects of VEGF originating specifically 
from NSPCs on seizures and their sequelae.  
 This project focused on characterizing the effects of knocking down NSPC-
derived VEGF on hippocampus-dependent behavior following excitotoxic injury as a 
way to investigate how NSPC-derived VEGF can modulate seizure-induced injury. 
Based on the functional importance of NSPCs and VEGF and the evidence of NSPCs 
being able to produce a significant amount of VEGF, I hypothesized that knocking down 
NSPC-derived VEGF would cause more severe behavioral impairments following 
chemical-induced excitotoxic injury.  
 This study used VEGFfl/flNestinCreERT2 mouse model that enables NSPC-
specific VEGF KD upon TAM injection22, 23. To induce excitotoxicity injury, an 
intraperitoneal (IP) injection of KA or vehicle (V) to KD and Con mice was administered. 
As an agonist of kainite receptors, KA is widely used to induce seizures in rodents and 
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causes strong excitotoxicity24. After TAM-induced recombination and KA injection, all 
mice began behavioral testing consisting of a novel arm test in a Y maze and an OLT 
for accessing short-term spatial memory, and an EPM for assessing anxiety-like 
behavior. Each of these tasks is a widely used assay for hippocampus-dependent 
behaviors25.  
 Con mice injected with V (ConV) were expected to show unimpaired memory and 
baseline anxiety-like behavior, such as avoidance of open areas, compared to other 
groups of mice. Con mice injected with KA (ConKA) and KD mice injected with V (KDV) 
were expected to show impaired memory and increased anxiety-like behavior compared 
to ConV. KD mice injected with KA (KDKA) were expected to exhibit the worst impaired 
memory and most increased anxiety-like behavior among the four groups of mice.  
This study investigated the functional consequences of NSPC-specific VEGF KD 
on memory and anxiety. Defining the functional effects of NSPC-derived growth factors 
and cytokines is a critical step in the successful implementation of NSPCs as 









VEGFfl/fl mice from Genentech, Inc were crossed with heterozygous 
NestinCreERT2 mice from The Jackson Laboratory (strain 01621). We used both male 
and female offspring of 8-10 weeks old of these breeders for experiments. Genotyping 
primers are detailed in Table 1. All mice were administered with IP injection of TAM 
(180mg/kg/d) dissolved in sunflower oil for 5 days. On the third day after the last TAM 
injection, mice were administered with IP injection of either KA (15mg/kg) or vehicle 
(saline). Seizure activity was observed in all mice during a period of 4 hours following 
KA injections. The experimental design yielded four different groups of mice: ConV 
(n=10), ConKA (n=15), KDV (n=11), KDKA (n=12). Two weeks following either KA or 
vehicle injection, mice underwent three behavioral tests consisted of a novel arm in a Y 
maze test, an OLT and an EPM. All animal use was in accordance with the Guide for 
the Care and Use of Laboratory Animals published by the National Institutes of Health 
and approved by The Ohio State University Institutional Animal Care and Use 
Committee (protocol #2016A00000068). 
Table 1 
Gene Primer Sequence 
 F  (5' → 3') R  (5' → 3') 
Cre-F GCGGTCTGGCAGTAAAAACTATC  
Cre-R  GTGAAACAGCATTGCTGTCACTT 
VEGF-F TCCGTACGACGCATTTCTAG  




Novel Arm Test in Y Maze  
Novel arm tests were conducted in a symmetrical Y-shaped maze with three 
grey, opaque plastic arms (37 cm × 6 cm × 13 cm) angled 120° from each other and a 
camera was positioned centrally above the Y maze. Each arm was identical inside and 
had no intramaze cues. Spatial cues were placed on the surrounding walls outside the 
Y maze.  
In the training trial, mice were released into one arm of the Y maze (release arm) 
and allowed to explore the maze with one arm blocked (novel arm) for 10 minutes. After 
a 2-hour intertrial interval (ITI) with the barrier to the novel arm removed, mice were 
released in the same arm as in the training trial and allowed to explore all arms for 10 
minutes during the testing trial. This ethologically relevant test was based on rodents’ 
inherent preference for novelty (novel arm in this experiment) and introduced no positive 
and negative reinforcement and very little stress to mice. The duration of time spent in 
each arm, frequency of visits to each arm, and latency to investigate the novel arm 
registered in the recorded videos were manually calculated by 2-3 observers blind to the 
genotype and treatment of the mice. Automated tracking software (Noldus EthoVision) 
was used to determine total distance traveled and average velocity of all mice to confirm 
that there were no inherent differences in activity or motor ability between mice.  
Object Location Test (OLT)  
OLTs were conducted in 4 open field areas (40 cm × 39 cm × 30 cm) made of 
white, opaque acrylic sheets with a camera positioned above the boxes. Spatial cues 
were placed on the surrounding walls outside the box. A transparent, plastic cone filled 
8 
 
with orange sand (6.5 cm high) and a grey, plastic, and elephant-like toy (9 cm high) 
were used as objects.  
In preparation for the OLT that would be conducted the next day, all mice were 
habituated to the open field with no objects for three 10-minute trials separated by an ITI 
of 1 h on day 1. On the day 2 training trial, mice were allowed to investigate the two 
different objects in the open field for 10 minutes. After a 1-hour ITI, one of the two 
objects was moved to a different place compared to that in the training trial and mice 
were allowed to investigate the objects for 10 minutes during the testing trial. Similar to 
the novel arm test of Y maze, this ethologically relevant test was also based on rodents’ 
inherent preference for novelty (the object at a different location in this experiment) and 
introduced no positive and negative reinforcement and very little stress to mice. 
Investigation time with each object during each trial registered in recorded videos were 
manually scored by 2-3 observers blind to the genotype and treatment of the mice. 
Object investigation was defined as a mouse’s nose being towards and within 2 cm of 
the object. Climbing the object was not considered as object investigation. Fractional 
investigation time was calculated as (investigation time of moved object) / (investigation 
time of both stationary and moved objects). Automated tracking software (Noldus 
EthoVision) was used to determine total distance traveled and average velocity of all 
mice to confirm that there were no inherent differences in activity or motor ability 
between mice.  
Elevated Plus Maze (EPM)  
The EPM consisted of two open arms (6 cm × 34.5 cm) at 90° angles to two 
closed arms (6 cm × 34.5 cm × 21.5 cm) and all arms extend from a common central 
9 
 
platform (6 cm × 6 cm). The maze was elevated 70.5 cm above the ground and a 
camera was positioned centrally above the maze. Mice were allowed to explore all 
arms. Time and visits to the relatively exposed, open arms were used as a measure of 
anxiety, with avoidance of the open arms reflecting high anxiety. Mice’s frequency of 
visits to and duration of time spent in closed versus open arms registered in recorded 
videos were manually scored by 2-3 observers blind to the genotype and treatment of 
the mice. 
 
Statistical Analysis  
A two-way ANOVA was used to determine if there were any statistical differences 
between the four experimental groups, and a contingency table test was used to 
determine the relation between the sample values of each experiment group and two 
different categorical variables which are contingent on one the other. Sidak’s multiple 
comparisons tests were performed to determine which groups were statistically different 
from each other. All statistical analyses were performed using GraphPad Prism software 









NSPC specific VEGF KD and KA induced excitotoxicity 
To study the effects of NSPC-derived VEGF KD, I used VEGFfl/flNestinCreERT2 
mice following TAM injection to specifically knock down VEGF expression in NSPCs. 
This mouse model has the CreER
T2 
gene under the nestin promoter, allowing for NSPC 
specific expression of cre recombinase19. Upon TAM binding to the estrogen receptor, 
the cre recombinase can translocate into the nucleus, allowing for excision of exon3 
leading to VEGF KD. (Fig. 1 A)18. To study the effect of excitotoxicity injury in the 
context of NSPC-specific VEGF KD, we administered an IP injection of KA or V to KD 
and Con mice. This experimental design yielded four different groups of mice: ConV, 
ConKA, KDV, and KDKA (Fig. 1 B). 










Fig. 1. Mouse model and experimental design. (A) VEGFfl/flNestinCreER
T2 
mouse model. (B) Cre 
positive (KD) and negative (Con) mice were given IP injections of TAM (180 mg/kg/d) for 5 days. Mice 
were given a two-day break before V or KA injection (15mg/kg). This yielded four groups: ConV, ConKA, 
KDV, and KDKA. After one day, mice’s hippocampi were dissected for assessment of VEGF expression, 
hilar degeneration and microgliosis. Two weeks after either vehicle or KA inject, mice underwent 





Preliminary data from my lab show that VEGF mRNA expression significantly 
decreased in KDV mice compared to ConV mice, indicating the success of VEGF KD 
(Fig. 2 A). My lab’s preliminary data also show that VEGF expression increased after 
KA treatment, in accordance with published data, and this increase in VEGF expression 
was reduced in KD mice compared to Con mice (Fig. 2 A)14. Furthermore, KD mice 
displayed more markers of KA-induced injury than Con mice. Specifically, KDKA mice 
showed increased Iba1 immunofluorescence, a sign of microglial activation, compared 
to the other three groups (Fig. 2 B, C). In addition, more KDKA mice exhibited positive 
fluorojade C (FJC) staining than ConKA mice did, a marker of neurodegeneration (Fig. 
2 D, E). Cumulatively, these in vivo data suggest that VEGF KD in NSPCs may 

















































Fig. 2.  VEGF KD and KA induced excitotoxicity (A) VEGF mRNA of Con and KD mice injected with V 
or KA was quantified by rt-qPCR. KD mice showed less VEGF expression compared to Con mice (two-
way ANOVA, genotype, #p=0.0048, F (1,51) =8.685; KA, p=0.0816, F (1,51) =8.685), but KA treatment 
decreased more VEGF expression in KD mice than in Con mice (Sidak’s multiple comparisons test, 
*p=0.0048). (B) Representative images of Iba1% staining in the DG in the four groups of mice. (Scale 
bars: 100 μm.) (C) KA treated mice showed increased Iba1% staining compared to V treated mice (two-
way ANOVA, genotype, p=0.1330 F (1,51) =2.331, KA, ****p<0.0001, F (1,51) =27.77). There was no 
difference in fold change in Iba1% staining between V injected Con and KD mice, but KA injected KD 
mice showed increased Iba1% staining compared to Con mice (Sidak’s multiple comparisons test, 
*p=0.0283). (D) Representative images of FJC+ staining in ConKA and KDKA mice. (Scale bars: 100 
μm.) (E) More KD mice showed hilar FJC+ degeneration than Con mice (Contingency test, Chi-






KA and VEGF KD impaired hippocampus-dependent short-term spatial memory in 
mice 
The novel arm test was conducted in a Y maze to assess mice’s hippocampus-
dependent short term spatial memory (Fig. 3 A, B). Mice have an inherent preference 
for novelty and if they have accurate memory for the training trial, they should show 
preference for visiting the previously blocked arm. This preference for the novel arm 
was therefore used as a measure of short-term memory. While more ConKA, KDV, 
KDKA mice visited either the familiar or release arms instead of novel arm, the 
difference compared to ConV was not significant (Fig. 3 C). Additionally, there was a 
similar trend in KD mice showing an increased latency to investigate the novel arm (Fig. 
3 D). Collectively, even though it did not reach significance, the data seem to indicate a 


































Fig. 3.  Short term spatial memory performance of mice based on novel arm test. (A, B) Schematic 
drawing of novel arm of Y maze test. (C) There was no significant difference of visiting novel arm first 
instead of other arms among four groups of mice (Contingency table test, Chi-square= 5.810, p= 0.1212) 
(D) There was no significant difference of latency to visit novel arm after leaving releasing arm among 
four groups of mice (two-way ANOVA, genotype, p=0.6835, F (1,44) =0.1684; KA, p=0.8907, F (1,44) 
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The OLT was also conducted to assess mice’s hippocampus-dependent short 
term spatial memory (Fig. 4 A, B, C). Similar to the novel arm of in a Y maze test, mice 
with intact hippocampal memory should show a preference for novel stimulus, which in 
this case was the object in the novel location (i.e., the moved object). During the training 
trial, mice in four groups investigated both objects for similar amounts of time, which 
indicates that mice had no inherent preference for either object (Fig. 4 D). During the 
testing trial, KA treated mice spent less time investigating moved object compared to V 
treated mice, indicating impaired memory caused by KA treatment (Fig. 4 E). KD mice 
also spent less time investigating moved object compared to Con mice in the V treated 
groups (Fig. 4 E), which implies VEGF KD alone impaired mice’s short-term spatial 
memory. During both training and testing trials, VEGF KD and KA treatment had no 
effects on total investigation time of both moved and stationary objects among four 
groups of mice (Fig. 4 F, G). However, in the testing trial KDKA mice spent more time 




































Fig. 4.  Short term spatial memory performance of mice based on OLT. (A, B, C) Schematic drawing 
of OLT. (D) In training trial, there was no significant difference of preferring visiting either moved or 
stationary object among four group of mice (two-way ANOVA, KD, p=0.3829, F (1,32) =0.7827; KA, 
p=0.7839, F (1,32) =0.7647). (E) In testing trial, KA treated mice spent less time investigating moved 
object compared to V treated mice (two-way ANOVA: *p=0.032); KD mice spent less time investigating 
moved object compared to Con mice (two-way ANOVA: genotype, **p=0.0007, F (1,32) =14.16; KA, 
*p=0.0320, F (1,32) =5.027); ConKA mice spent less time investigating moved object compared to ConV 
(Sidak’s multiple comparisons test, *p=0.0207). (F) There was no significant difference of investigation 
time of moved and stationary objects among four groups of mice in training trial ((two-way ANOVA, 
genotype, p=0.2032, F (1,32) =1.688; KA, p=0.1535, F (1,32) =2.138). (G)VEGF KD and KA treatment 
had no main effects on investigation time of moved and stationary objects among four groups of mice in 
testing trial. KDKA ((two-way ANOVA, genotype, p=0.1628, F (1,32) =2.051; KA, p=0.1535, F (1,32) 
=2.768); KDKA mice spent more time investigating both objects compared to KDV mice (Sidak’s multiple 
comparisons test, **p=0.0089); KDKA mice spent more time investigating both objects compared to 
ConKA mice (Sidak’s multiple comparisons test, **p=0.0063). Data represents mean ± SEM. 











Time in Open Arms 
Entries in All Arms 
KA and VEGF KD had no effect on anxiety-like behavior 
The EPM, a common test for anxiety, was conducted. The EPM consisted of two 
open arms and two closed arms (Fig. 5 A). Time and visits to the relatively exposed, 
open arms were used as measures of anxiety-like behavior, with avoidance of the open 
arms reflecting high anxiety. Time spent and number of entries in open arms did not 
differ among the four groups of mice (Fig. 5 B, C). The lack of differences indicates KA 
and VEGF KD might not have impacts on mice’s anxiety. Number of entries in both 
closed and open arms did not differ statistically among the hour groups of mice (Fig. 5 











Fig. 5.  Anxiety-like behavior performance of mice based on EPM. (A) Schematic drawing of EPM. 
The red arrow indicated the releasing place of every mouse. (B) There was no significant difference of 
time spent in open arms among four group of mice (two-way ANOVA, genotype, p=0.4152, F (1,32) 
=0.6815; KA, p=0.3236, F (1,32) =1.005). (C) There was no significant difference of entries in open arms 
among four group of mice (two-way ANOVA, genotype, p=0.0999, F (1,32) =2.872; KA, p=0.5377, F 
(1,32) =0.3882). (D) There was no significant difference of number of entries in closed and open arms 
among four groups of mice (two-way ANOVA, genotype, p=0.1754, F (1,32) =1.920; KA, p=0.4958, F 
(1,32) =0.4748). Data represents mean ± SEM. 




This thesis investigated the behavioral changes associated with loss of NSPC-
derived VEGF after KA induced excitotoxic injury. Excitotoxic tissue damage could be 
caused by seizures, and changes in mood and behavior are also observed after 
seizures2, 22, 23. Previous studies have shown that VEGF is upregulated after seizure 
induced excitotoxicity and can protect against seizure and excitotoxic injury in rats 14, 15. 
Incidentally, our lab has shown that NSPCs in the DG of the hippocampus produce a 
significant amount of VEGF. Importantly, the DG of the hippocampus is a crucial brain 
region for modulating memory and emotions by producing new neurons8, 9. So, we 
hypothesized that knocking down NSPC-derived VEGF would cause more severe 
behavioral impairments following excitotoxic injury. 
Similar to previous study, our preliminary data also show that VEGF expression 
was increased after KA treatment compared to that after V treatment. Additionally, we 
found that VEGF expression was decreased in the KD mice compared to the Con mice 
after KA treatment. Importantly, the preliminary data also show that KA induced 
excitotoxic injury was exacerbated in the absence of NSPC-derived VEGF, including 
increased neuroinflammation and neuron degeneration. The exacerbated excitotoxicity 
might indicate the later impairments in behavioral functions. 
To investigate specific behavioral changes, including hippocampus-dependent 
short-term spatial memory and anxiety-like behavior, associated with loss of NSPC-
derived VEGF after KA induced excitotoxic injury, we utilized the novel arm test in a Y 
maze test, the OLT, and the EPM. Results from the novel arm test seem to suggest a 
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potential impact on short-term spatial memory by knocking down VEGF in NSPCs, even 
though they did not reach significance. And results from the OLT show that KA 
treatment impaired mice’s short-term spatial memory. Surprisingly, results from the OLT 
have also suggested that VEGF KD alone impair mice’s short-term spatial memory 
which may or may not be further impacted by KA induced excitotoxicity. This particular 
finding indicates that NSPC-derived VEGF might be essential for the proper memory 
function. Noticeably, in the testing trial KDKA mice spent more time investigating both 
stationary and moved objects compared to KDV and ConKA mice, suggesting that there 
might be potential interaction impact of VEGF KD and KA treatment on locomotor 
abilities and motivation to investigate. However, in both training and testing trials there 
were no main effects of VEGF KD and KA treatment on total investigation time of both 
objects.  
 
Even though our data suggest that VEGF KD and KA treatment impacted the 
short-term spatial memory which is modulated by the DG of the hippocampus, the 
results from the EPM indicate that they had no effects on mice’s anxiety-like behavior 
which the DG also plays an important role in8, 9.  By contrast, one previous study has 
shown that VEGF treatment helped preserve normal anxiety functioning in mice 
completely after acute seizures17. So, I think my experiment might possibly fail to 
capture the impact of KA treatment and VEGF KD on mice’s anxiety-like behavior.  
For future studies, it will be helpful to analyze the data from the open field 
habituation trials during the first day of OLT as another way to assess mice’s anxiety-
like behavior.  Mice’s time spent in the center of the open field could be used to 
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measure the anxiety-like behavior, with more time spent in the center reflecting less 
anxiety24. The data from the open field habituation trials could be used to confirm 
whether the lack of effect of KA treatment and VEGF KD on mice’s anxiety-like behavior 
as shown in the EPM is valid or not. In order to determine the potential memory 
exacerbation of KA effect by KD of NSPC-derived VEGF, future studies could elongate 
the training trial’s duration of the OLT to provide mice more time to form spatial memory. 
Because by doing that decreases the difficulty of OLT, it would avoid the ceiling effect of 
assessing mice’s short-term spatial memory and could highlight the exacerbation effect 















Here we investigated behavioral changes associated with loss of NSPC-derived 
VEGF after KA induced excitotoxic injury, because of the importance of VEGF on 
protecting against seizures caused excitotoxic injuries, and also the crucial role of 
NSPCs, which produce a significant amount of VEGF, on mediating memory and 
emotions. Overall, our results suggest that KA treatment and VEGF KD could potentially 
impair mice’s short-term spatial memory based on the novel arm test in a Y maze and 
the OLT but had no effects on mice’s anxiety-like behavior based on the EPM. This 
thesis aimed to contribute to the further research of NSPCs’ therapeutic functions by 
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